Congratulations to Dr Raphaële Clément, University of California, Santa Barbara, United States, for being selected as the recipient of the 2024 Lectureship.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d4tb90199a | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Controlled PVA Release from Chemical-Physical Interpenetrating Networks to Treat Dry Eyes.
ACS Omega
January 2025
Centre for Ocular Research & Education (CORE), School of Optometry & Vision Science, University of Waterloo, 200 University Avenue West, Waterloo N2L 3G1, ON, Canada.
Dry eye disease is becoming increasingly prevalent, and lubricating eye drops, a mainstay of its treatment, have a short duration of time on the ocular surface. Although there are various drug delivery methods to increase the ocular surface residence time of a topical lubricant, the main problem is the burst release from these delivery systems. To overcome this limitation, herein, a chemical-physical interpenetrating network (IPN) was fabricated to take control over the release of poly(vinyl alcohol) (PVA), a well-known therapeutic agent used to stabilize tear film, from gelatin methacrylate (GelMA) hydrogels.
View Article and Find Full Text PDFEnvironmental impact of commonly used anaesthetic agents: systematic literature review with narrative synthesis.
BJA Open
March 2025
Department of Anaesthesia, The William Harvey Hospital, Ashford, UK.
Background: Increasing awareness of the potential environmental impact of volatile anaesthetic agents has stimulated increased use of total i.v. anaesthesia.
View Article and Find Full Text PDFCongratulations to our 2024 Lectureship runners-up: Dr Maxx Arguilla and Dr Phillip Milner.
View Article and Find Full Text PDF2024 Lectureship winner: Raphaële Clément, University of California, Santa Barbara, United States.
J Mater Chem B
January 2025
Congratulations to Dr Raphaële Clément, University of California, Santa Barbara, United States, for being selected as the recipient of the 2024 Lectureship.
View Article and Find Full Text PDFOperationalizing goal setting as an outcome measure in trials involving patients with frailty, multimorbidity or complexity.
Contemp Clin Trials Commun
February 2025
Ageing and Movement Research Group, Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Background/aims: In the absence of disease-modifying therapies for Parkinson's disease, much research focuses on improving quality of life, health and wellbeing. It is important to evaluate potential treatments and innovative care models in a robust and standardised way. Disease-specific outcomes have limitations in older people, those with cognitive impairment, multimorbidity, disability or short life expectancy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!